Alpha 2.0
Login Register
» Authors » Maria Celeste Colucci

Maria Celeste Colucci

Explore the profile of Maria Celeste Colucci including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 43
Followers 0
Related Specialties
General Medicine
Oncology
Microbiology
Top 10 Co-Authors
Maria Alejandra Picconi
Rita Mariel Correa
Jorge Alejandro Basiletti
Rolando Herrero
Maria Dolores Fellner
Maribel Almonte
Carolina Wiesner
Joaquin Victor Gonzalez
Laura Mendoza
Armando Baena
Published In
PLoS One
BMJ Open
Infect Agent Cancer
Rev Argent Microbiol
Papillomavirus Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs
Downham L, Rol M, Forestier M, Romero P, Mendoza L, Mongelos P, et al.
Int J Cancer . 2024 Apr; 155(5):816-827. PMID: 38602045
Overexpression of HPV-oncoproteins E6 and E7 is necessary for HPV-driven cervical carcinogenesis. Hence, these oncoproteins are promising disease-specific biomarkers. We assessed the technical and operational characteristics of the 8-HPV-type OncoE6/E7...
2.
Human papillomavirus genotyping using next generation sequencing (NGS) in cervical lesions: Genotypes by histologic grade and their relative proportion in multiple infections
Basiletti J, Valls J, Poklepovich T, Fellner M, Rol M, Alonso R, et al.
PLoS One . 2022 Nov; 17(11):e0278117. PMID: 36417453
Sensitive and specific genotyping of human papillomaviruses (HPVs) is critical for the surveillance and monitoring of the vaccine effectiveness. Here, HPV genotypes were identified in 137 cervical samples with different...
3.
Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America
Correa R, Baena A, Valls J, Colucci M, Mendoza L, Rol M, et al.
PLoS One . 2022 Jul; 17(7):e0272205. PMID: 35905130
The proportion of HPV16 and 18-associated cervical cancer (CC) appears rather constant worldwide (≥70%), but the relative importance of the other HR-HPV differs slightly by geographical region. Here, we studied...
4.
A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections
Ma Z, Gharizadeh B, Cai X, Li M, Fellner M, Basiletti J, et al.
Infect Agent Cancer . 2022 Mar; 17(1):9. PMID: 35313939
Background: Sexually transmitted infections (STIs) are prevalent throughout the world and impose a significant burden on individual health and public health systems. Missed diagnosis and late treatment of STIs can...
5.
Strong reduction in prevalence of HPV16/18 and closely related HPV types in sexually active adolescent women following the introduction of HPV vaccination in Argentina
Gonzalez J, Deluca G, Correa R, Liotta D, Basiletti J, Fellner M, et al.
Papillomavirus Res . 2020 Nov; 10:100208. PMID: 33161174
No abstract available.
6.
Baseline prevalence and type distribution of Human papillomavirus in sexually active non-vaccinated adolescent girls from Argentina
Gonzalez J, Deluca G, Liotta D, Correa R, Basiletti J, Colucci M, et al.
Rev Argent Microbiol . 2020 Aug; 53(1):11-19. PMID: 32788072
In 2011, Argentina launched a government-funded national Human papillomavirus (HPV) immunization program incorporating a bivalent HPV vaccine, with a 0-1-6-month schedule, for girls 11 years of age, born after January...
7.
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol
Almonte M, Murillo R, Sanchez G, Gonzalez P, Ferrera A, Picconi M, et al.
BMJ Open . 2020 May; 10(5):e035796. PMID: 32448795
Introduction: Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology...